相关实验视频

Updated: Jul 5, 2025

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

多发性骨髓瘤的阿育吠陀评估和治疗:一个病例报告

Abhijeet Sarjerao Shirkande¹, Ankita Abhijeet Shirkande², Jayashree Changade³

¹Department of Dravyaguna (Ayurvedic Materia Medica & Pharmacology), Dr. D. Y. Patil College of Ayurved & Research Center, Pimpri, Pune of Dr. D. Y. Patil Vidyapeeth (Deemed to be University) Pune, India; Shree VishwAngad Ayurved, Panchakarma, Yoga Clinic & Research Center, Sahakar Nagar, Pune, India.

Journal of Ayurveda and integrative medicine

|January 24, 2024

概括

这份病例报告显示,综合阿育吠陀和传统护理有效地管理了多发性骨髓瘤. 艾尔维达治疗导致患者在没有副作用的情况下恢复,这表明了进一步研究的潜力.

科学领域:

综合性瘤学是一种综合性瘤学.
补充和替代医学补充和替代医学
血液性恶性瘤血液性恶性瘤

背景情况:

多发性骨髓瘤是一种血液性恶性瘤,需要有效的管理策略.
传统的治疗方法,如化疗和骨髓移植,都有局限性和副作用.
结合传统和替代医学的综合方法正在引起人们的注意.

研究的目的:

通过综合方法报告多发性骨髓瘤的成功管理.
探索阿育吠陀医学的作用与多发性骨髓瘤的传统护理相结合.
要突出一个以患者为中心的治疗决策的案例研究.

主要方法:

一名59岁的多发性骨髓瘤男性患者接受了化疗和类固醇治疗.
患者选择了阿育吠陀疗法,而不是骨髓移植.
阿育吠陀的原则确定了瓦塔和皮塔多沙的不平衡影响患者的状况.
实施了个性化的阿育吠陀治疗计划.

主要成果:

患者经历了多发性骨髓瘤症状的恢复.
没有报告阿育吠陀干预的不良影响.
观察到疲劳,疼痛,恶心和精神压力的显著改善.
综合性方法促进了治疗的积极结果.

结论:

艾尔维达医学可以在治疗多发性骨髓瘤方面发挥支持作用.
综合护理可能为癌症患者提供可行的替代或补充策略.
需要进一步进行临床试验,以验证阿育吠陀治疗多发性骨髓瘤的疗效.

关键词:

艾尔维达是一种阿育韦德.化疗化疗是一种化学疗法.整体方法是一个整体的方法.综合医学是一个整体的医学.多发性骨髓瘤是一种多发性骨髓瘤.

更多相关视频

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...